Stop the Virus in its Tracks

AuraVax is a privately-held biotechnology company built around proprietary nasal vaccine technology. AuraVax is driven to respond to urgent societal needs created by the COVID-19 pandemic.

Meet the Team

Dr. Navin Varadarajan, PhD
Dr. Navin Varadarajan, PhD
Co-founder & CSO

Navin is a scientist/engineer and entrepreneur who has been working in immunology for 10+ years. Pioneered multiple molecular and cellular technologies for immunotherapies and vaccines.

Matthew Meyer, JD
Matthew Meyer, JD
Chief Business Advisor

Matthew is an experienced corporate attorney and business executive with both large and emerging growing life science companies including Pfizer, Novartis and Myriad.

Focus on Covid-19

Platform vaccination for respiratory viruses (e.g. SARS, MERS etc.) with a focus on COVID-19

Read more

Addressing Unmet Needs

Simple at-home vaccination may save lives and reduce costs while preventing community transmission

Learn more